Robert L Parry

Title: The Innovations of Robert L. Parry

Introduction

Robert L. Parry is an accomplished inventor based in Silver Spring, MD (US). He has made significant contributions to the field of medical science, particularly in the treatment of tumors. His innovative work has led to the development of a patent that addresses critical health issues.

Latest Patents

Robert L. Parry holds a patent for the "Use of Mullerian Inhibiting Substance for Treating Certain Tumors." This application focuses on the treatment of specific tumors using an effective amount of the glycoprotein Mullerian Inhibiting Substance (MIS). It also discusses the use of the C-terminal fragment of MIS for tumor treatment. Furthermore, the patent includes DNA sequences encoding the C-terminal fragment of MIS, vectors containing the DNA sequence, and transformed host cells capable of producing the C-terminal fragment. The application also explores gene therapy treatments aimed at inhibiting the growth of certain tumors. Additionally, it presents a method for modulating class I histocompatibility antigens with MIS and EGF.

Career Highlights

Robert L. Parry is associated with The General Hospital Corporation, where he has been able to apply his expertise in medical research and innovation. His work has been instrumental in advancing therapeutic approaches for tumor treatment.

Collaborations

Throughout his career, Robert has collaborated with notable professionals in the field, including Patricia K. Donahoe and Tai Wai Chin. These collaborations have further enriched his research and contributed to the success of his innovations.

Conclusion

Robert L. Parry's contributions to medical science through his patent on the use of Mullerian Inhibiting Substance exemplify the impact of innovative thinking in healthcare. His work continues to inspire advancements in tumor treatment and gene therapy.